Table 1.
Depression, anxiety, and sleep quality by post-treatment remission status*
| Assessment | Nonremitters (N=60)* |
Remitters (N=64) |
P |
|---|---|---|---|
| Depression | |||
| HAM-D-17 total score | |||
| Baseline | 23.8 (SD=5.9) | 22.0 (SD=4.8) | 0.08 |
| 16 weeks | 12.6 (SD=5.8) | 3.1 (SD=4.6) | <0.0001 |
| BDI-2 total score | |||
| Baseline | 32.2 (SD=8.6) | 28.1 (SD=8.3) | 0.009 |
| 16 weeks | 11.4 (SD=6.8) | 5.3 (SD=6.2) | <0.0001 |
| Anxiety | |||
| Beck Anxiety Inventory (BAI) | |||
| Baseline | 15.5 (SD=8.7) | 12.5 (SD=8.4) | 0.06 |
| 16 weeks | 10.1 (SD=6.8) | 5.5 (SD=6.3) | 0.0002 |
| Sleep Quality | |||
| PSQI Global Score** | |||
| Baseline | 11.7 (SD=3.7) | 9.1 (SD=3.7) | 0.0002 |
| 16 weeks | 9.4 (SD=4.0) | 5.9 (SD=3.6) | <0.0001 |
Continuous variables are reported as Mean (Standard Deviation) (SD). Categorical variables are number of patients (%).
Pittsburgh Sleep Quality Inventory Global Score (lower score indicates higher sleep quality)